Picture of Merck & Co logo

MRK — Merck & Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Momentum

Relative Strength (%)
1m+15.14%
3m+40.54%
6m+38.57%
1yr+33.79%
Volume Change (%)
10d/3m+0.06%
Price vs... (%)
52w High-1.23%
50d MA+8.75%
200d MA+16.88%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)12.77
PEG Ratio (f)2.96
EPS Growth (f)4.51%
Dividend Yield (f)3.12%
Valuation (ttm)IndustryMarket
Price to Book Value5.8
Price to Tang. Bookn/a
Price to Free Cashflow18.55
Price to Sales4.39
EV to EBITDA13.7

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.46%
Return on Equity41.02%
Operating Margin28.85%

Financial Summary

Year End 31st DecUnit201720182019202020212022E2023ECAGR / Avg
Total Revenue$m40,12242,29439,12141,51848,70457,909.9456,589.094.12%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-34.06+2.5-4.1+18.55+44.92+7.78-0.04n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Latest News & Insights for MRK

Two factors that could move the Merck & Co Inc (NYQ:MRK) share price background image

Two factors that could move the Merck & Co Inc (NYQ:MRK) share price

The Merck & Co Inc (NYQ:MRK) share price is currently trading at $88.5. But given that there is still a lot of uncertainty about the health of the wider economy, the question now is what the future holds for it... To try and predic...

Will the Merck & Co Inc share price run continue? background image

Will the Merck & Co Inc share price run continue?

In this article we will quickly re-cap the broker forecasts for Merck & Co Inc (NYQ:MRK). The Merck & Co Inc share price has risen by 7.78% over the past month and it’s currently trading at 85.03. For investors considering whet...

Four clues to the quality of Merck & Co Inc (NYQ:MRK) background image

Four clues to the quality of Merck & Co Inc (NYQ:MRK)

Warren Buffett makes it look so easy: find high-quality companies, wait for a fair price to buy, and then hold them... forever. The problem of course is that these stocks are hard to find - but there are signs that Merck & Co Inc N...

Upbeat broker recommendations for Merck & Co Inc background image

Upbeat broker recommendations for Merck & Co Inc

The Merck & Co Inc (NYQ:MRK) share price has risen by 6.66% over the past month and it’s currently trading at 82.9. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will c...

Why Merck & Co Inc (NYQ:MRK) could be a stock to watch background image

Why Merck & Co Inc (NYQ:MRK) could be a stock to watch

Given widespread disruption and uncertainty in the stock market, it is more important than ever to find high quality stocks for your portfolio. That means safe, profitable companies with strong balance sheets. We all like the idea of i...

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Merck & Co EPS forecast chart

Profile Summary

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Directors

Last Annual
December 31st, 2021
Last Interim
March 31st, 2022
Incorporated
July 28th, 1970
Public Since
June 15th, 1946
No. of Shareholders
99,932
No. of Employees
68,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
2,528,805,025

MRK Share Price Performance

Latest News for MRK

Upcoming Events for MRK

Merck & Co Inc at ASCO Annual Meeting

Dividend For MRK.BA - 0.1380 USD

Dividend For MRCK34.SA - 0.4149 BRL

Dividend For MRK.N - 0.6900 USD

Q2 2022 Merck & Co Inc Earnings Call

Q2 2022 Merck & Co Inc Earnings Release

Q3 2022 Merck & Co Inc Earnings Call

Q3 2022 Merck & Co Inc Earnings Release

Similar to MRK

Picture of Abbvie logo

Abbvie

us flag iconNew York Stock Exchange

Picture of Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

FAQ

Or unlock with your email

Or unlock with your email